UK patients get early access to AbbVie’s hepatitis regimen
admin 11th May 2017 Uncategorised 0AbbVie’s glecaprevir/pibrentasvir (G/P) has become the first treatment for chronic hepatitis C to be included in the UK’s Early Access to Medicines Scheme (EAMS).
More: UK patients get early access to AbbVie’s hepatitis regimen
Source: News